Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Recruiting now · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Radiation-induced Dermatitis
In brief
To evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.
Key facts
- Study ID
- NCT07353671
- Run by
- West China Hospital
- People needed
- 60
- Starts
- 2026-03-01
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-03-25
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age and Gender: Patients aged 18 to 80 years (inclusive of boundary values), regardless of gender.
- Diagnosis and Treatment: Patients with head and neck cancer (including nasopharyngeal carcinoma) who have been confirmed by histopathology and require radical radiotherapy or postoperative adjuvant radiotherapy.
- Performance Status: Patients with an ECOG Performance Status score of 0 to 2.
- Consent: Patients who voluntarily agree to participate in this study and sign the informed consent form.
You may not qualify if…
- Prior Radiotherapy: Patients with a history of prior radiotherapy to the target area.
- Baseline Skin Condition: Baseline skin condition in the treatment area that may interfere with efficacy assessment (e.g., presence of open wounds, infection, rash, psoriasis, etc.).
- Systemic Diseases: Presence of connective tissue diseases or other systemic dermatoses.
- Known Allergies: Known allergy to any component of the investigational product (Meilian Fuxin Solution).
- Prior Clinical Research: Participation in other interventional clinical studies within the past 3 months and use of any investigational drugs or devices.
- Investigator Discretion: Subjects judged by the investigator to be unsuitable for participation in this clinical study.
Where it is running
- Sichuan University West China Hospital, Chengdu, Sichuan — Chengdu, Sichuan, China (enrolling)
- Sichuan University West China Hospital — Chengdu, Sichuan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.